Silencing of FOXA2 decreases E-cadherin expression and is associated with lymph node metastasis in oral cancer.

Silencing of FOXA2 decreases E-cadherin expression and is associated with lymph node metastasis in oral cancer.:

Related Articles

Silencing of FOXA2 decreases E-cadherin expression and is associated with lymph node metastasis in oral cancer.

Oral Dis. 2020 Jan 19;:

Authors: Bow YD, Wang YY, Chen YK, Su CW, Hsu CW, Xiao LY, Yuan SS, Li RN

Abstract

OBJECTIVES: FOXA2 gene methylation links to the progression of cancers, but has not been documented in oral cancer. Herein, we explore the role of FOXA2 in the migration of oral cancer cells.

MATERIAL AND METHODS: Methylation-specific PCR was applied for gene methylation. Wound healing and transwell experiments were tested for cell migration. FOXA2 expression in oral cancer tissues was addressed by immunohistochemistry, followed by statistical analysis of its association with clinical manifestations and patient survival.

RESULTS: FOXA2 bound to the promoter of CDH1 and enhanced the expression of its gene product E-cadherin, and decreased the cancer cell migration activity. High FOXA2 expression in oral cancer tissues was associated with high E-cadherin expression, decreased lymph node metastasis, and increased patient survival.

CONCLUSION: FOXA2-E-cadherin link is involved in regulation of oral cancer cell metastasis and provides a new insight for the tumor suppressor activity of FOXA2 in oral cancer.

PMID: 31957176 [PubMed - as supplied by publisher]